mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
2e-05 |
mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0003 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0005 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
etoposide |
CTRPv2 |
pan-cancer |
AAC |
0.089 |
0.003 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.098 |
0.003 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
0.097 |
0.003 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
-0.13 |
0.003 |
mRNA |
Tipifarnib |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.004 |